Yokohama City University School of Medicine
Yusuke Ito, M.D., Ph.D., Assistant Professor, Yokohama City University School of Medicine
2015 – present Postdoctoral fellow, Marianne Sadar Lab, BC Cancer Agency, Genome Science Center
2011 – 2015 Graduate Student, Department of Urology, Yokohama City University School of Medicine
Awarded the degree of Ph.D.
1998 – 2004 School of Medicine, Yokohama City University
Awarded the degree of M.D.
2004 – 2006 National Hospital Organization Tokyo Medical Center, Resident
April 2006 – May 2007, Staff of Urology, Department of Urology, Yokohama City University School of Medicine
June 2007 – May 2009, Staff of Urology, Kanagawa Prefectural Ashigarakami Hospital
June 2009 – March 2011, Staff of Urology, Yokosuka Kyousai Hospital
September 2018 - , Assistant Professor, Department of Urology, Yokohama City University School of Medicine
1. Ito Y, Sadar MD. Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens. Res Rep Urol 2018;10:23-32
2. Ito Y, Naiki-Ito A, Kato H, Suzuki S, Kuno T, Ishiguro Y, et al. Chemopreventive effects of angiotensin II receptor type 2 agonist on prostate carcinogenesis by the down-regulation of the androgen receptor. Oncotarget 2018;9:13859-69
3. Izumi K, Ito Y, Miyamoto H, Miyoshi Y, Ota J, Moriyama M, et al. Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence. Oncotarget 2016;7:14153-60
4. Ito Y, Ishiguro H, Kobayashi N, Hasumi H, Watanabe M, Yao M, et al. Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity. The Prostate 2015;75:1009-19